Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-03-31 to 2023-04-21
Current total value of award: $12766.05
Description: 4560482629!XOLAIR 150 MG/ML SYRINGEML